LDHA and acute myeloid leukemia: Although preliminary and in vitro results, these data could argue for an even higher efficacy of ALDH blockade in unfavorable or refractory/relapsed AML, while most leukemia treatments are usually less active in these subtypes, probably due to clonal selection of leukemia cells co-expressing chemotherapy resistance genes [80].